Abstract:Yaling Wang, 1, 2 Ben Wang, 1, 2 Yingxue Huang, 1 Yangfan Li, 1, 2 Sha Yan, 1 Hongfu Xie, 1– 3 Yiya Zhang, 1– 3 Ji Li 1– 3 1 Department of Dermatology, Xiangya Hospital, Central South University, Changsha, People's Republic of China; 2 Hunan Key Laboratory of Aging Biology, Xiangya Hospital, Central South University, Changsha, People's Republic of China; 3 National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, People's Republic of China Correspondence: Ji Li; Yiya Zhang, Department of Dermatology, Xiangya Hospital, Central South University, Changsha, People's Republic of China, Tel +86-731-84327472, Email ; Objective: Rosacea is a chronic inflammatory skin disease with high morbidity. Previous studies have described the contribution of skin barrier dysfunction (SBD) in the progression of rosacea, but the specific mechanism remains unclear. In this study, we aim to investigate the key genes that may involve SBD-mediated rosacea aggravation. Methods: In this study, we evaluated the SBD patterns of rosacea based on the expression of 23 skin barrier-related genes (SBRGs) using a consensus clustering analysis, and revealed the SBD-mediated immune cells infiltration in rosacea using GSE65914 dataset. The key genes associated with SBD and rosacea progression were identified using WGCNA analysis and then verified in rosacea mice model. Results: Two distinct SBD patterns (moderate- and high-SBD patterns) were determined in rosacea. GO, KEGG and GSEA analysis revealed the differently immune-related signal pathways between two SBD patterns in rosacea. The XCell immune cell assays showed that the increased immune infiltration with SBD. Subsequently, the WGCNA analysis identified STAT3 as the hub gene related to rosacea and SBD, and correlation analysis revealed that STAT3 could contribute to the progression of rosacea partly by dysregulating immune infiltration via activating the cytokine/chemokines signal. Finally, the up-regulated STAT3 was verified in the epidermis of rosacea tissues and correlated with SBRGs expression using IHC and epidermal transcriptome data of rosacea. The vivo experiment showed that tape stripping-induced SBD evidently induced the expression of STAT3 and increased CD4 + T cell infiltration in LL37-induced rosacea-like skin lesion in mice. Conclusion: In conclusion, our results showed that the destruction of the skin barrier aggravates the inflammation levels and immune infiltration of rosacea partly by activating STAT3-mediated cytokine signal pathways in keratinocytes. Graphical Keywords: rosacea, skin barrier, immune, STAT3, WGCNA Graphical Rosacea is a chronic inflammatory skin disease characterized by flushing, persistent erythema, papules and pustules, telangiectasia and phyma, especially on the cheek, nose, chin, forehead and eyes. 1 The incidence of rosacea varies in different areas of the world and a cross-sectional study showed that about 3.48% of individuals are affected in China. 2 According to the National Rosacea Society Expert Committee in 2017, the updated classification of rosacea is based on phonotypes linked to clinical manifestations and provides criterion of diagnosis and severity assessment of the disease. 3 Although the pathophysiology of rosacea remains unclear, genetic factors, dysregulation of the innate and adaptive immune system, vascular and neuronal dysfunction, and microorganisms such as Demodex folliculorum appear to be involved. 4 Above these, Zuo et al found overcleaning were positively associated with rosacea, 5 indicating that rosacea is also associated with impairment of the skin barrier. Skin barrier plays a critical role in skin homeostasis. Various skin barrier-related genes (SBRGs) have been reported to be involved in the progression of skin disease via regulating the skin barrier. The tight junction protein and Filaggrin (FLG) are important SBRGs, 6 playing a central role for the physical integrity of the skin barrier. The biological and chemical stimulations from the external environment disrupted the skin barrier by reducing tight junctions, triggering epithelial alarmin, including barrier alarms (KRT6A, KRT16), AMPs (DEFB4B, CAMP, LCN2, S100A7, S100A8, S100A9) and KLK enzyme. 7 Previous investigations have shown that patients with rosacea have impaired facial skin barrier, characterized by increased PH, abnormal fatty acid composition and increased trans epidermal water Loss (TEWL). 8,9 Previous research demonstrated the dysregulated SBRGs i -Abstract Truncated-

Aquaporin-3 Upregulation Promotes Rosacea-Like Inflammation by Inducing NF-kB Activation in Keratinocytes and Th17 Cell Differentiation

Targeting Aquaporin-3 Attenuates Skin Inflammation in Rosacea.

Aquaporin 3 and Skin

Keratinocyte-Immune Cell Crosstalk in a STAT1-Mediated Pathway: Novel Insights Into Rosacea Pathogenesis

TLR7 Promotes Skin Inflammation Via Activating NFκB-mTORC1 Axis in Rosacea.

Targeting the STAT3/IL-36G Signaling Pathway Can Be a Promising Approach to Treat Rosacea

Dietary supplementation of n-3 PUFAs ameliorates LL37-induced rosacea-like skin inflammation via inhibition of TLR2/MyD88/NF-κB pathway

Single-cell transcriptomics reveals aberrant skin-resident cell populations and identifies fibroblasts as a determinant in rosacea

Multi-Transcriptomic Analysis and Experimental Validation Implicate a Central Role of STAT3 in Skin Barrier Dysfunction Induced Aggravation of Rosacea

Increased Serum Levels of CCL3, CXCL8, CXCL9, and CXCL10 in Rosacea Patients and Their Correlation with Disease Severity.

Signaling pathways and targeted therapy for rosacea

Quercetin attenuates inflammation in rosacea by directly targeting p65 and ICAM-1

A positive feedback loop between mTORC1 and cathelicidin promotes skin inflammation in rosacea

Aging-Conferred SIRT7 Decline Inhibits Rosacea-Like Skin Inflammation by Modulating Toll-Like Receptor 2‒NF-κB Signaling

OPN Promotes Pro-Inflammatory Cytokine Expression Via ERK/JNK Pathway and M1 Macrophage Polarization in Rosacea

High-sensitive sensory neurons exacerbate rosacea-like dermatitis in mice by activating γδ T cells directly

IL-17A-neutralizing antibody ameliorates inflammation and fibrosis in rosacea by antagonizing the CXCL5/CXCR2 axis

Integrated Omics Reveal the Molecular Characterization and Pathogenic Mechanism of Rosacea.

Tranexamic acid ameliorates rosacea symptoms through regulating immune response and angiogenesis

LncRNA NEAT1 targets miR-125/ADAM9 mediated NF-κB pathway in inflammatory response of rosacea

N2-polarized Neutrophils Reduce Inflammation in Rosacea by Regulating Vascular Factors and Proliferation of CD4+ T Cells.